Using the CRISPR/Cas9 technology, Bence et al. [34] selectively and efficiently disrupted the mutant Tmc1 allele in Beethoven mice, and this prevented deafness in Beethoven mice up to 1 year post-injection. Here, TMC1 is linked to deafness.